GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Stereotaxis Inc (AMEX:STXS) » Definitions » Piotroski F-Score

Stereotaxis (Stereotaxis) Piotroski F-Score

: 2 (As of Today)
View and export this data going back to 2004. Start your Free Trial

Warning Sign:

Piotroski F-Score of 2 is low, which usually implies poor business operation.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Stereotaxis has an F-score of 2. It is a bad or low score, which usually implies poor business operation.

The historical rank and industry rank for Stereotaxis's Piotroski F-Score or its related term are showing as below:

STXS' s Piotroski F-Score Range Over the Past 10 Years
Min: 1   Med: 2   Max: 6
Current: 2

During the past 13 years, the highest Piotroski F-Score of Stereotaxis was 6. The lowest was 1. And the median was 2.


Stereotaxis Piotroski F-Score Historical Data

The historical data trend for Stereotaxis's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stereotaxis Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Piotroski F-Score
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.00 4.00 2.00 2.00 2.00

Stereotaxis Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Piotroski F-Score Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.00 1.00 1.00 2.00 2.00

Competitive Comparison

For the Medical Instruments & Supplies subindustry, Stereotaxis's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Stereotaxis Piotroski F-Score Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Stereotaxis's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Stereotaxis's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Net Income was -5.347 + -4.957 + -5.369 + -5.04 = $-20.71 Mil.
Cash Flow from Operations was -2.802 + -2.931 + -0.967 + -2.439 = $-9.14 Mil.
Revenue was 6.548 + 7.859 + 7.799 + 4.565 = $26.77 Mil.
Gross Profit was 3.876 + 4.187 + 4.059 + 2.738 = $14.86 Mil.
Average Total Assets from the begining of this year (Dec22)
to the end of this year (Dec23) was
(53.413 + 50.711 + 48.315 + 44.528 + 41.909) / 5 = $47.7752 Mil.
Total Assets at the begining of this year (Dec22) was $53.41 Mil.
Long-Term Debt & Capital Lease Obligation was $5.06 Mil.
Total Current Assets was $33.27 Mil.
Total Current Liabilities was $13.25 Mil.
Net Income was -4.086 + -5.134 + -4.917 + -4.154 = $-18.29 Mil.

Revenue was 7.037 + 6.152 + 7.657 + 7.301 = $28.15 Mil.
Gross Profit was 4.924 + 4.67 + 4.567 + 4.309 = $18.47 Mil.
Average Total Assets from the begining of last year (Dec21)
to the end of last year (Dec22) was
(60.985 + 57.429 + 56.678 + 56.075 + 53.413) / 5 = $56.916 Mil.
Total Assets at the begining of last year (Dec21) was $60.99 Mil.
Long-Term Debt & Capital Lease Obligation was $5.49 Mil.
Total Current Assets was $43.25 Mil.
Total Current Liabilities was $14.29 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Stereotaxis's current Net Income (TTM) was -20.71. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Stereotaxis's current Cash Flow from Operations (TTM) was -9.14. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Dec22)
=-20.713/53.413
=-0.38778949

ROA (Last Year)=Net Income/Total Assets (Dec21)
=-18.291/60.985
=-0.29992621

Stereotaxis's return on assets of this year was -0.38778949. Stereotaxis's return on assets of last year was -0.29992621. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Stereotaxis's current Net Income (TTM) was -20.71. Stereotaxis's current Cash Flow from Operations (TTM) was -9.14. ==> -9.14 > -20.71 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Dec23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec22 to Dec23
=5.062/47.7752
=0.10595455

Gearing (Last Year: Dec22)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec21 to Dec22
=5.488/56.916
=0.0964228

Stereotaxis's gearing of this year was 0.10595455. Stereotaxis's gearing of last year was 0.0964228. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Dec23)=Total Current Assets/Total Current Liabilities
=33.267/13.247
=2.51128557

Current Ratio (Last Year: Dec22)=Total Current Assets/Total Current Liabilities
=43.246/14.291
=3.02610034

Stereotaxis's current ratio of this year was 2.51128557. Stereotaxis's current ratio of last year was 3.02610034. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Stereotaxis's number of shares in issue this year was 82.725. Stereotaxis's number of shares in issue last year was 76.311. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=14.86/26.771
=0.55507826

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=18.47/28.147
=0.65619782

Stereotaxis's gross margin of this year was 0.55507826. Stereotaxis's gross margin of last year was 0.65619782. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Dec22)
=26.771/53.413
=0.50120757

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Dec21)
=28.147/60.985
=0.46153972

Stereotaxis's asset turnover of this year was 0.50120757. Stereotaxis's asset turnover of last year was 0.46153972. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+0+1+0+0+0+0+1
=2

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Stereotaxis has an F-score of 2. It is a bad or low score, which usually implies poor business operation.

Stereotaxis  (AMEX:STXS) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Stereotaxis Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Stereotaxis's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Stereotaxis (Stereotaxis) Business Description

Traded in Other Exchanges
Address
710 North Tucker Boulevard, Suite 110, St. Louis, MO, USA, 63101
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service and accessories stream. The company generates the majority of revenue from the United States.
Executives
Paul J Isaac 10 percent owner 530 FIFTH AVENUE, 20TH FLOOR, NEW YORK NY 10036
Myriam Curet director 1020 KIFER ROAD, SUNNYVALE CA 94086
David Benfer director 5 SELDEN AVENUE, BRANFORD CT 06404
Kimberly R. Peery officer: Chief Financial Officer C/O STEREOTAXIS, INC., 4320 FOREST PARK AVENUE: SUITE 100, ST. LOUIS MO 63108
Kevin M. Barry officer: Chief Legal Officer & Secretar 4320 FOREST PARK AVENUE, 100, ST. LOUIS MO 63108
Ross B Levin director 530 FIFTH AVENUE, 20TH FLOOR, NEW YORK NY 10036
Fariba Fischel Ghodsian 10 percent owner 10990 WILSHIRE BOULEVARD, SUITE 1400, LOS ANGELES CA 90024
Dafna Capital Management Llc 10 percent owner 10990 WILSHIRE BOULEVARD, SUITE 1400, LOS ANGELES CA 90024
David Leo Fischel director 10990 WILSHIRE BOULEVARD, SUITE 1400, LOS ANGELES CA 90024
Arun Swarup Menawat director 2412 EIGHTH LINE, OAKVILLE A6 L6H6S9
Joe E Kiani director 4320 FOREST PARK AVENUE, SUITE 100, ST. LOUIS MO 63108
Paul Brathwaite officer: VP Research & Development C/O STEREOTAXIS, INC., 4320 FOREST PARK AVENUE, SUITE 100, ST. LOUIS MO 63108
Martin C Stammer officer: Chief Financial Officer C/O STEREOTAXIS, INC., 4320 FOREST PARK AVENUE, SUITE 100, ST. LOUIS MO 63108
Nathan Fischel director 10990 WILSHIRE BOULEVARD, SUITE 1400, LOS ANGELES CA 90024
Duane Desisto director C/O INSULET CORPORATION, 9 OAK PARK DRIVE, BEDFORD MA 01730